Oryzon Genomics S.A.

DB:ORN Stock Report

Market Cap: €94.9m

Oryzon Genomics Management

Management criteria checks 3/4

Oryzon Genomics' CEO is Carlos Manuel Arjol, appointed in Jan 2000, has a tenure of 24.83 years. total yearly compensation is $503.42K, comprised of 68.6% salary and 31.4% bonuses, including company stock and options. directly owns 4.61% of the company’s shares, worth €4.38M. The average tenure of the management team and the board of directors is 5.1 years and 9 years respectively.

Key information

Carlos Manuel Arjol

Chief executive officer

US$503.4k

Total compensation

CEO salary percentage68.6%
CEO tenure24.8yrs
CEO ownership4.6%
Management average tenure5.1yrs
Board average tenure9yrs

Recent management updates

Recent updates

CEO Compensation Analysis

How has Carlos Manuel Arjol's remuneration changed compared to Oryzon Genomics's earnings?
DateTotal CompensationSalaryCompany Earnings
Sep 30 2024n/an/a

-US$5m

Jun 30 2024n/an/a

-US$4m

Mar 31 2024n/an/a

-US$3m

Dec 31 2023US$503kUS$346k

-US$4m

Sep 30 2023n/an/a

-US$4m

Jun 30 2023n/an/a

-US$4m

Mar 31 2023n/an/a

-US$5m

Dec 31 2022US$451kn/a

-US$5m

Compensation vs Market: Carlos Manuel's total compensation ($USD503.42K) is about average for companies of similar size in the German market ($USD474.54K).

Compensation vs Earnings: Carlos Manuel's compensation has increased whilst the company is unprofitable.

CEO

Carlos Manuel Arjol

24.8yrs

Tenure

US$503,422

Compensation

Dr. Carlos Manuel Buesa Arjol Co-Founded Oryzon Genomics S.A. in 2000 and has been its Chairman and Chief Executive Officer since 2001 and serves as its President and served as its Member of Financial Advi...

Leadership Team

NamePositionTenureCompensationOwnership
Carlos Manuel Arjol
Co-Founder24.8yrsUS$503.42k4.61%
€ 4.4m
Enric Condomines
COO & CFO4.4yrsno datano data
Jordi Pey
Scientific Director3.8yrsno datano data
Xavier Ribera
Head of Internal Audit & Complianceno datano datano data
Augusto Rubio
Secretaryno datano datano data
Emili Cortada
Director of Business Developmentno datano datano data
Neus Bernado
Director of Industrial Propertyno datano datano data
Michael Ropacki
Medical Director of SNC5.8yrsno datano data
Sonia Paloma Bezon
Director of Clinical Operationsno datano datano data

5.1yrs

Average Tenure

Experienced Management: ORN's management team is seasoned and experienced (5.1 years average tenure).

Board Members

NamePositionTenureCompensationOwnership
Carlos Manuel Arjol
Co-Founder23.8yrsUS$503.42k4.61%
€ 4.4m
Howard Fillit
Member of Scientific Advisory Boardno datano datano data
Isabel Aguilera Navarro
Independent Director9yrsUS$49.68kno data
Lori Kunkel
Member of Scientific Advisory Board6.8yrsno datano data
Manuel López-Figueroa
Lead Independent Director4.5yrsUS$72.86kno data
Josep Echarri Torres
Director22.8yrsUS$29.81k1.98%
€ 1.9m
Tamara Maes
VP of the Board & President of Scientific Advisory Board24.8yrsUS$41.95k3.96%
€ 3.8m
Ramon Ramon
Independent Director9yrsUS$54.10k0.029%
€ 27.6k
Leon Hooftman
Member of Scientific Advisory Boardno datano datano data
Antonio Melero
Independent Director9yrsUS$54.10kno data
Felipe Cardoso
Member of Scientific Advisory Boardno datano datano data
Jose Molinuevo
Member of Scientific Advisory Boardno datano datano data

9.0yrs

Average Tenure

66yo

Average Age

Experienced Board: ORN's board of directors are considered experienced (9 years average tenure).